SSA
NARI

Schonfeld Strategic Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,300
Closed -$3.33M – 2587
2024
Q4 		$3.33M Buy
65,300
+3,268
+5% +$161K 0.02% 629
2024
Q3 		$2.56M Sell
62,032
-83,853
-57% -$4.03M 0.02% 781
2024
Q2 		$7.02M Sell
145,885
-113,539
-44% -$5.03M 0.05% 459
2024
Q1 		$12.4M Buy
+259,424
New +$13.9M 0.08% 299
2023
Q3 		– Sell
-36,600
Closed -$2.13M – 2409
2023
Q2 		$2.13M Buy
36,600
+4,933
+16% +$311K 0.02% 731
2023
Q1 		$1.96M Sell
31,667
-22,809
-42% -$1.37M 0.02% 688
2022
Q4 		$3.46M Sell
54,476
-21,224
-28% -$1.54M 0.03% 606
2022
Q3 		$5.5M Buy
75,700
+49,500
+189% +$3.69M 0.05% 498
2022
Q2 		$1.78M Buy
26,200
+21,200
+424% +$1.52M 0.02% 788
2022
Q1 		$453K Buy
+5,000
New +$409K ﹤0.01% 1436
2021
Q3 		– Sell
-85,969
Closed -$8.02M – 2537
2021
Q2 		$8.02M Buy
+85,969
New +$8.33M 0.09% 337

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Schonfeld Strategic Advisors's NARI Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 65,300 shares — an estimated $3.33M sold.

Schonfeld Strategic Advisors first reported a position in NARI in Q2 2021 and held it in 11 quarters. The position peaked at $12.4M in Q1 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Schonfeld Strategic Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 65,300 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $3.33M.
  • Schonfeld Strategic Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Inari Medical, Inc. Common Stock position peaked at $12.4M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.